查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1631227

心臟生物標記診斷檢測套組的全球市場 - 全球產業分析，規模，佔有率，成長，趨勢，預測(2032年)

Cardiac Biomarker Diagnostic Test Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032
出版日期: | 出版商: Fairfield Market Research | 英文 209 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

隨著人們對心血管疾病的認識不斷提高以及診斷技術的進步，心臟生物標記診斷檢測試劑盒市場預計將顯著增長。這些試劑盒對於早期發現和管理心臟相關疾病至關重要，能夠及時介入並改善患者的治療效果。預計 2023 年至 2032 年期間心臟生物標記診斷檢測試劑盒市場規模將以 5.70% 的複合年增長率穩步增長，2025 年達到 18.9 億美元，2032 年達到 27.9 億美元。

這些診斷解決方案的需求是由生活方式相關的健康風險和全球人口老化共同推動的，迫切需要創新工具來應對心血管健康課題。由於對創新、準確和及時的診斷工具的需求不斷增加，心臟生物標記診斷測試試劑盒市場預計將呈現強勁成長。透過 POC 測試、AI 整合以及新興市場不斷增長的機會，該領域有望改變心血管護理並改善全球健康。

心肌梗塞和心臟衰竭等心血管疾病發生率的上升是市場成長的主要動力。心臟生物標記檢測試劑盒能夠早期發現這些重要疾病並確保有效管理。敏感檢測和多重免疫測定的創新提高了心臟生物標記檢測的準確性和效率，從而得到了醫療保健專業人員的廣泛採用。醫療保健專業人員和患者對早期檢測重要性的認識不斷提高，促使對心臟生物標記診斷測試套件的需求增加。

本報告提供全球心臟生物標記診斷檢測套組市場相關調查，提供市場概要，以及各產品類型，各適應症，各最終用途，及各地區趨勢，及市場參與市場企業的競爭趨勢等資訊。

目錄

第1章 摘要整理

第2章 市場概要

  • 市場定義和市場區隔
  • 市場動態
  • 價值鏈分析
  • 波特的五力分析
  • COVID-19影響分析
  • 烏克蘭·俄羅斯糾紛的影響
  • 經濟概要
  • 大環境分析

第3章 全球心臟生物標記診斷檢測套組市場預測，2019年～2032年

  • 全球心臟生物標記診斷檢測套組市場預測，各產品類型，金額(10億美元)，2019年～2032年
  • 全球心臟生物標記診斷檢測套組市場預測，各適應症，金額(10億美元)，2019年～2032年
  • 全球心臟生物標記診斷檢測套組市場預測，各最終用途，金額(10億美元)，2019年～2032年
  • 全球心臟生物標記診斷檢測套組市場預測，各地區，金額(10億美元)，2019年～2032年

第4章 北美的心臟生物標記診斷檢測套組市場預測，2019年～2032年

第5章 歐洲的心臟生物標記診斷檢測套組市場預測，2019年～2032年

第6章 亞太地區的心臟生物標記診斷檢測套組市場預測，2019年～2032年

第7章 南美的心臟生物標記診斷檢測套組市場預測，2019年～2032年

第8章 中東·非洲的心臟生物標記診斷檢測套組市場預測，2019年～2032年

第9章 競爭情形

  • 各最終用途vs各適應症熱圖
  • 各製造廠商vs各適應症熱圖
  • 企業市場佔有率分析，2024年
  • 競爭儀表板
  • 企業簡介
    • Abbott Laboratories
    • Danaher Corporation
    • Bio-Rad Laboratories
    • Thermo Fisher Scientific, Inc.
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche Ltd.
    • Siemens AG
    • BioMerieux SA
    • Randox Laboratories Ltd.
    • 其他

第10章 附錄

簡介目錄

The cardiac biomarker diagnostic test kits market is poised for significant growth, driven by increasing awareness of cardiovascular diseases and advancements in diagnostic technologies. These kits are essential for early detection and management of heart-related conditions, enabling timely intervention and improving patient outcomes. The cardiac biomarker diagnostic test kits market is projected to grow at a steady CAGR of 5.70% between 2023 and 2032, reaching an estimated valuation of USD 1.89 billion by 2025 and USD 2.79 billion by 2032.

Market Insights

The demand for these diagnostic solutions is propelled by a combination of lifestyle-related health risks and an aging global population, creating an urgent need for innovative tools to address cardiovascular health challenges. The cardiac biomarker diagnostic test kits market is set to witness robust growth as demand for innovative, accurate, and timely diagnostic tools rises. With expanding opportunities in POC testing, AI integration, and emerging markets, the sector is on a trajectory to transform cardiovascular care and improve global health outcomes.

Market Drivers

  • 1. Rising Cardiovascular Disease Prevalence: The growing incidence of cardiovascular conditions like myocardial infarction and heart failure is a major driver of market growth. Cardiac biomarker test kits enable early detection, ensuring effective management of these critical conditions.
  • 2. Technological Advancements: Innovations in high-sensitivity assays and multiplex immunoassays have enhanced the precision and efficiency of cardiac biomarker testing, fostering increased adoption among healthcare providers.
  • 3. Increased Healthcare Awareness: Growing awareness among healthcare professionals and patients about the importance of early detection has led to greater demand for cardiac biomarker diagnostic test kits.

Business Opportunities

  • 1. Point-of-Care (POC) Testing: Expanding POC testing capabilities presents a significant opportunity for manufacturers. Rapid and user-friendly POC test kits allow for immediate, on-site diagnosis, catering to emergency and remote healthcare settings.
  • 2. AI Integration: Incorporating artificial intelligence (AI) into diagnostic solutions can enhance accuracy by analyzing complex biomarker patterns and providing predictive insights. This integration positions companies at the forefront of innovation in cardiac diagnostics.
  • 3. Emerging Markets: Growing healthcare investments and rising cardiovascular disease prevalence in regions such as South Asia and the Pacific offer untapped opportunities for market expansion.

Regional Analysis

  • Europe: Europe leads the global market due to its advanced healthcare infrastructure and emphasis on preventive care. The region's focus on research and adherence to clinical standards further solidifies its dominance.
  • South Asia and Pacific: This region is the fastest-growing market segment, driven by an increased burden of cardiovascular diseases and significant investments in healthcare infrastructure.
  • North America: North America remains a key market due to high awareness levels and the availability of advanced diagnostic technologies.

Key Players Leading companies in the cardiac biomarker diagnostic test kits market include:

  • Abbott Laboratories
  • Danaher Corporation
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Siemens AG
  • BioMerieux SA
  • Randox Laboratories Ltd.

These organizations continue to drive innovation and expand their market presence through strategic collaborations, product launches, and technological advancements.

Market Segmentation The market is segmented as follows:

  • By Product Type: Brain Natriuretic Peptide (BNPs) Test Kits Creatine Kinase MB (CK-MB) Test Kits Troponin (I&T) Test Kits Myoglobin Test Kits Others
  • By Indication: Angina Pectoris Acute Myocardial Infarction Congestive Heart Failure Others
  • By End-Use: Hospitals Diagnostic Laboratories Outpatient Clinics Academic & Research Institutes
  • By Region: North America Europe Asia Pacific Latin America Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Cardiac Biomarker Diagnostic Test Kits Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

  • 3.1. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 3.1.1. Key Highlights
      • 3.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
      • 3.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
      • 3.1.1.3. Troponin (I&T) Test Kit
      • 3.1.1.4. Myoglobin Test Kit
      • 3.1.1.5. Others
  • 3.2. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
    • 3.2.1. Key Highlights
      • 3.2.1.1. Angina Pectoris
      • 3.2.1.2. Acute Myocardial Infarction
      • 3.2.1.3. Congestive Heart Failure
      • 3.2.1.4. Others
  • 3.3. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospitals
      • 3.3.1.2. Diagnostic Laboratories
      • 3.3.1.3. Outpatient Clinics
      • 3.3.1.4. Academic & Research Institutes
  • 3.4. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

  • 4.1. North America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
      • 4.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
      • 4.1.1.3. Troponin (I&T) Test Kit
      • 4.1.1.4. Myoglobin Test Kit
      • 4.1.1.5. Others
  • 4.2. North America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Angina Pectoris
      • 4.2.1.2. Acute Myocardial Infarction
      • 4.2.1.3. Congestive Heart Failure
      • 4.2.1.4. Others
  • 4.3. North America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Diagnostic Laboratories
      • 4.3.1.3. Outpatient Clinics
      • 4.3.1.4. Academic & Research Institutes
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 4.4.1.2. U.S. Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 4.4.1.3. U.S. Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 4.4.1.4. Canada Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 4.4.1.5. Canada Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 4.4.1.6. Canada Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

  • 5.1. Europe Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
      • 5.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
      • 5.1.1.3. Troponin (I&T) Test Kit
      • 5.1.1.4. Myoglobin Test Kit
      • 5.1.1.5. Others
  • 5.2. Europe Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Angina Pectoris
      • 5.2.1.2. Acute Myocardial Infarction
      • 5.2.1.3. Congestive Heart Failure
      • 5.2.1.4. Others
  • 5.3. Europe Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Diagnostic Laboratories
      • 5.3.1.3. Outpatient Clinics
      • 5.3.1.4. Academic & Research Institutes
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.2. Germany Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 5.4.1.3. Germany Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.4. U.K. Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.5. U.K. Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 5.4.1.6. U.K. Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.7. France Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.8. France Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 5.4.1.9. France Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.10. Italy Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.11. Italy Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 5.4.1.12. Italy Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.13. Turkey Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.14. Turkey Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 5.4.1.15. Turkey Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.16. Russia Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.17. Russia Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 5.4.1.18. Russia Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.19. Rest of Europe Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.20. Rest of Europe Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 5.4.1.21. Rest of Europe Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

  • 6.1. Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
      • 6.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
      • 6.1.1.3. Troponin (I&T) Test Kit
      • 6.1.1.4. Myoglobin Test Kit
      • 6.1.1.5. Others
  • 6.2. Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Angina Pectoris
      • 6.2.1.2. Acute Myocardial Infarction
      • 6.2.1.3. Congestive Heart Failure
      • 6.2.1.4. Others
  • 6.3. Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Diagnostic Laboratories
      • 6.3.1.3. Outpatient Clinics
      • 6.3.1.4. Academic & Research Institutes
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.2. China Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 6.4.1.3. China Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.4. Japan Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.5. Japan Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 6.4.1.6. Japan Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.7. South Korea Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.8. South Korea Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 6.4.1.9. South Korea Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.10. India Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.11. India Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 6.4.1.12. India Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.13. Southeast Asia Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.14. Southeast Asia Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 6.4.1.15. Southeast Asia Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.16. Rest of Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.17. Rest of Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 6.4.1.18. Rest of Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

  • 7.1. Latin America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
      • 7.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
      • 7.1.1.3. Troponin (I&T) Test Kit
      • 7.1.1.4. Myoglobin Test Kit
      • 7.1.1.5. Others
  • 7.2. Latin America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
      • 7.2.1.1. Angina Pectoris
      • 7.2.1.2. Acute Myocardial Infarction
      • 7.2.1.3. Congestive Heart Failure
      • 7.2.1.4. Others
  • 7.3. Latin America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Diagnostic Laboratories
      • 7.3.1.3. Outpatient Clinics
      • 7.3.1.4. Academic & Research Institutes
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.2. Brazil Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 7.4.1.3. Brazil Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 7.4.1.4. Mexico Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.5. Mexico Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 7.4.1.6. Mexico Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 7.4.1.7. Argentina Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.8. Argentina Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 7.4.1.9. Argentina Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 7.4.1.10. Rest of Latin America Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.11. Rest of Latin America Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 7.4.1.12. Rest of Latin America Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

  • 8.1. Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
      • 8.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
      • 8.1.1.3. Troponin (I&T) Test Kit
      • 8.1.1.4. Myoglobin Test Kit
      • 8.1.1.5. Others
  • 8.2. Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Angina Pectoris
      • 8.2.1.2. Acute Myocardial Infarction
      • 8.2.1.3. Congestive Heart Failure
      • 8.2.1.4. Others
  • 8.3. Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Diagnostic Laboratories
      • 8.3.1.3. Outpatient Clinics
      • 8.3.1.4. Academic & Research Institutes
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.2. GCC Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 8.4.1.3. GCC Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 8.4.1.4. South Africa Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.5. South Africa Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 8.4.1.6. South Africa Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 8.4.1.7. Egypt Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.8. Egypt Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 8.4.1.9. Egypt Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 8.4.1.10. Nigeria Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.11. Nigeria Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 8.4.1.12. Nigeria Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 8.4.1.13. Rest of Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.14. Rest of Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 8.4.1.15. Rest of Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By End Use vs by Indication Heat map
  • 9.2. Manufacturer vs by Indication Heatmap
  • 9.3. Company Market Share Analysis, 2024
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Abbott Laboratories
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Danaher Corporation
    • 9.5.3. Bio-Rad Laboratories
    • 9.5.4. Thermo Fisher Scientific, Inc.
    • 9.5.5. Becton, Dickinson and Company
    • 9.5.6. F. Hoffmann-La Roche Ltd.
    • 9.5.7. Siemens AG
    • 9.5.8. BioMerieux SA
    • 9.5.9. Randox Laboratories Ltd.
    • 9.5.10. Others

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations